Skip to main content
Premium Trial:

Request an Annual Quote

VolitionRx Begins Trading on NYSE MKT, Prices Public Offering at $3.75 per Share

NEW YORK (GenomeWeb) – Shares of Belgian diagnostics firm VolitionRx began trading on the New York Stock Exchange MKT today after an offering of 2,475,000 shares at $3.75 per share. 

The company's stock is now listed under ticker symbol "VNRX." It previously was listed on the OTCQB. 

The firm anticipates $8.5 million in net proceeds from the offering, which will be used to fund prospective colorectal cancer test trials with Hvidovre Hospital in Denmark and an ongoing study at University Hospital in Bonn, Germany. The funds will also go toward general working capital and other corporate purposes, VolitionRx said.   

National Securities, a wholly owned subsidiary of National Holdings, and Lake Street Capital Markets are the joint book-running agents on the offering. The Benchmark Company is the co-manager. VolitionRx has granted the underwriters a 30-day overallotment option to purchase an additional 371,250 additional shares at $3.75 per share. 

Volition expects to close the offering on Feb. 11. 

The company said in the fall that it planned to move to the NYSE and filed a prospectus for the offering. It is developing diagnostic tests based on nucleosomics technology, which identifies and measures nucleosomes in blood and other body fluids. 

In afternoon trading on Friday, its shares were up 5 percent at $4.30.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.